It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2018.
2018 | Hyderabad, Telangana, India | ActiveGlivita Pharma Private Limited, a active private limited company, was established on 09 January 2018 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999TG2018PTC121737. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
Its leadership includes Krishna Murthy Gudala (Director), Sampath Kumar Gudala (Director), Renuka Gudala (Director). It holds ₹7.82 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at H.No 3-5-1093/22 & 22/A Narayanaguda, Hyderabad, Telangana, 500029.
U74999TG2018PTC121737
121737
09 January 2018
₹0.50 M
₹0.50 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Glivita Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Krishna Murthy Gudala | Director | 09 Jan 2018 | Current |
| Sampath Kumar Gudala | Director | 09 Jan 2018 | Current |
| Renuka Gudala | Director | 09 Jan 2018 | Current |
| Arun Kumar Gudala | Director | 09 Jan 2018 | Current |
| Amarnath Gudala | Director | 09 Jan 2018 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Glivita Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 31.03% increase. The company also saw a substantial improvement in profitability, with a 88.95% increase in profit. The company's net worth dipped by a decrease of 4.79%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Glivita Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹78,238,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Nov 2019 | Others | ₹7.07 Cr | Open |
| 21 Dec 2018 | Others | ₹7.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Glivita Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Glivita Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glivita Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Glivita Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Progress on Glivita Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.
The activity A charge with Others of Rs. 70.74 M registered on 26 Nov 2019 with Charge ID 100307748 was modified on 28 Dec 2022. was completed.
A charge with Others of Rs. 7.50 M registered on 21 Dec 2018 with Charge ID 100227012 was modified on 28 Dec 2022. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 70.74 M with Charge ID 100307748 was registered on 26 Nov 2019. was documented.
A charge with Others amounted to Rs. 7.50 M with Charge ID 100227012 was registered on 21 Dec 2018. was recorded as a recent event.
The CIN of Glivita Pharma Private Limited is U74999TG2018PTC121737.
Glivita Pharma Private Limited is headquartered at H.No 3-5-1093/22 & 22/A Narayanaguda, Hyderabad, Telangana, 500029.
Glivita Pharma Private Limited was incorporated on 09 January 2018.
The current directors of Glivita Pharma Private Limited are
The primary industry of Glivita Pharma Private Limited is Trade.
Glivita Pharma Private Limited is unlisted.
The authorized capital of Glivita Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX